7Baggers
Quarterly
Annual
    Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 
      
    		       
      operating activities
    		       
      net profit/(loss) for the period
    		-131,035       
      reversal of finance income
    		-3,575 33,128 3,389 -35,239 -45,135 21,616 10,374 
      reversal of finance expenses
    		77,161 8,425 16,988 8,812 9,840 25,106 10,548 
      reversal of (gain)/loss on disposal of property, plant and equipment
    		-91       
      reversal of income taxes
    		2,508 5,790 645 -429 1,297   
      adjustments for non-cash items:
    		       
      non-cash consideration relating to revenue
    		-24,770 -580 -571 -589 -614 -634 -638 
      share of profit/(loss) of associates
    		5,796       
      share-based payment
    		17,281 15,908 17,184 19,880 13,688 13,873 13,537 
      depreciation
    		4,359 4,827 4,632 4,534 4,435 4,526 4,404 
      amortization
    		118 150 111 111 111 111 111 
      changes in working capital:
    		       
      inventories
    		-23,750 -19,799 -21,213 -17,068 -20,178 -26,697 -2,654 
      receivables
    		-11,286 -8,523 -13,535 -1,107 -9,608 -5,457 -376 
      prepayments
    		-3,904 -5,175 6,541 -2,603 -10,176 2,460 768 
      contract liabilities
    		-950 2,153 -115 -8,862 -256 -2,079 12,592 
      trade payables, accrued expenses and other payables
    		-19,025 -10,053 4,288 -4,920 14,236 23,415 14,568 
      increase/(decrease) in provisions
    		7,076       
      cash flows generated from/(used in) operations
    		-104,087       
      finance income received
    		3,588 4,471 4,174 4,524 3,879 1,463 2,980 
      finance expenses paid
    		-877 -7,040 -886 -6,840 -906 -7,268 -784 
      income taxes received/
    		-206       
      cash flows from/(used in) operating activities
    		-101,582       
      investing activities
    		       
      acquisition of property, plant and equipment
    		-199 63 -976 -444 -1,085 -3,782 -3,163 
      settlement of marketable securities
    		7,354 6,583 23,150 47,401 211,731 55,988 88,401 
      cash flows from/(used in) investing activities
    		7,155       
      financing activities
    		       
      repayment of borrowings
    		-2,786       
      proceeds from exercise of warrants
    		21,209 2,018 6,194 208 1,866 3,130 1,337 
      cash flows from/(used in) financing activities
    		18,423       
      increase/(decrease) in cash and cash equivalents
    		-76,004       
      cash and cash equivalents at january 1
    		392,164 0 0 0 444,767 0 0 
      effect of exchange rate changes on balances held in foreign currencies
    		4,079 -7,230 6,187 1,421 -6,386 -22,430 20,753 
      cash and cash equivalents at march 31
    		320,239    501,281   
      cash and cash equivalents include:
    		       
      bank deposits
    		320,239 -49,104 47,046 -107,059 501,281 -176,208 -66,226 
      net profit/(loss) for the year
    		       
      reversal of gain and loss on disposal of property, plant and equipment
    		   0 21 0 8 
      share of profit/(loss) of associate
    		       
      impairment of property, plant and equipment
    		       
      investment in associate
    		       
      proceeds from disposal of property, plant and equipment
    		 5      
      reimbursement for acquisition of property, plant and equipment
    		       
      development expenditures
    		       
      purchase of marketable securities
    		     -53,003 -71,139 
      payment of principal portion of lease liabilities
    		 -2,735 -2,618 -2,517 -2,568 -1,779 -1,414 
      net proceeds from borrowings
    		 -3,526      
      net proceeds from follow-on public offerings
    		       
      acquisitions of treasury shares, net of transactions costs
    		       
      payment of withholding taxes under stock incentive programs
    		       
      cash and cash equivalents at december 31
    		       
      short-term marketable securities
    		     12,645 2,169 
      net profit / (loss) for the period
    		  -162,223 -121,432 -110,914  -168,958 
      increase / (decrease) in provisions
    		  9,469 1,642 1,983  1,425 
      share of profit / (loss) of associate
    		  6,794 7,450 1,227  3,697 
      cash flows generated from / (used in) operations
    		  -127,637 -149,820 -150,043  -100,761 
      income taxes received /
    		  -370 -992 26  -268 
      cash flows from / (used in) operating activities
    		  -124,719 -153,128 -147,044  -98,833 
      reimbursement from acquisition of property, plant and equipment
    		      0 
      cash flows from / (used in) investing activities
    		  22,220 46,957 210,646  14,099 
      acquisition of treasury shares, net of transaction costs
    		      1 
      cash flows from / (used in) financing activities
    		  143,358 -2,309 -702  -76 
      increase / (decrease) in cash and cash equivalents
    		  40,859 -108,480 62,900  -84,810 
      cash and cash equivalents at september 30
    		       
      net proceeds from convertible senior notes
    		     0 0 
      cash and cash equivalents at june 30
    		       
      reversal of tax charge
    		     5,349 -167 
      net increase in cash and cash equivalents
    		       
      cash flows from / used in investing activities
    		       
      b.
    		       
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.